Cargando…

New perspective to evaluate N1 staging: The peripheral lymph node metastasis status of non‐small cell lung cancer

BACKGROUND: Lymph node (LN) metastasis status is the decision‐making basis for the surgical procedure and adjuvant therapy modalities. Fewer studies have previously focused on LN metastasis in N1 station, especially on peripheral lymph node (PLN) metastasis in N1 station. This study aimed to reveal...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Jiaqi, Liu, Lei, Wang, Guige, Huang, Cheng, Chen, Yeye, Zhang, Ye, Guo, Chao, Li, Shanqing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons Australia, Ltd 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6885437/
https://www.ncbi.nlm.nih.gov/pubmed/31617316
http://dx.doi.org/10.1111/1759-7714.13213
_version_ 1783474737849040896
author Zhang, Jiaqi
Liu, Lei
Wang, Guige
Huang, Cheng
Chen, Yeye
Zhang, Ye
Guo, Chao
Li, Shanqing
author_facet Zhang, Jiaqi
Liu, Lei
Wang, Guige
Huang, Cheng
Chen, Yeye
Zhang, Ye
Guo, Chao
Li, Shanqing
author_sort Zhang, Jiaqi
collection PubMed
description BACKGROUND: Lymph node (LN) metastasis status is the decision‐making basis for the surgical procedure and adjuvant therapy modalities. Fewer studies have previously focused on LN metastasis in N1 station, especially on peripheral lymph node (PLN) metastasis in N1 station. This study aimed to reveal the metastasis status of PLN of non‐small cell lung cancer (NSCLC), and investigate its effects on N staging. METHODS: We retrospectively evaluated a consecutive series of patients who underwent curative resection for histologically confirmed N1 NSCLC. Propensity score matching (PSM) was used to analyze the effects of PLN on N staging. RESULTS: A total of 105 patients with confirmed pathological N1 (pN1) stage NSCLC with solitary nodule and without neoadjuvant therapy were enrolled into the study: 55 patients had intraperipheral LN metastasis (IPLNM), and 50 patients had extra‐peripheral LN metastasis (EPLNM). Before PSM analysis, type of location (P = 0.002), surgical procedure (P = 0.008), number of positive LNs (P = 0.029), number of LNs removed (P = 0.010), lobe of lung cancer (P = 0.031), and vascular invasion (P = 0.049) showed significant differences between the two groups. After PSM analysis, statistically there were differences in type of location (P = 0.034), number of positive LNs (P = 0.008) and vascular invasion (P = 0.049) between them. CONCLUSION: PLN metastasis was a quite common pattern of LN metastasis in N1 station of NSCLC. IPLNM occurred more frequently in central NSCLC and NSCLC with vascular invasion, and thoracotomy was likely to secure more accurate PLN staging. Clinicians should pay great attention to PLN dissection. Follow‐up data will be needed in order to detect the prognosis of IPLNM patients.
format Online
Article
Text
id pubmed-6885437
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher John Wiley & Sons Australia, Ltd
record_format MEDLINE/PubMed
spelling pubmed-68854372019-12-09 New perspective to evaluate N1 staging: The peripheral lymph node metastasis status of non‐small cell lung cancer Zhang, Jiaqi Liu, Lei Wang, Guige Huang, Cheng Chen, Yeye Zhang, Ye Guo, Chao Li, Shanqing Thorac Cancer Original Articles BACKGROUND: Lymph node (LN) metastasis status is the decision‐making basis for the surgical procedure and adjuvant therapy modalities. Fewer studies have previously focused on LN metastasis in N1 station, especially on peripheral lymph node (PLN) metastasis in N1 station. This study aimed to reveal the metastasis status of PLN of non‐small cell lung cancer (NSCLC), and investigate its effects on N staging. METHODS: We retrospectively evaluated a consecutive series of patients who underwent curative resection for histologically confirmed N1 NSCLC. Propensity score matching (PSM) was used to analyze the effects of PLN on N staging. RESULTS: A total of 105 patients with confirmed pathological N1 (pN1) stage NSCLC with solitary nodule and without neoadjuvant therapy were enrolled into the study: 55 patients had intraperipheral LN metastasis (IPLNM), and 50 patients had extra‐peripheral LN metastasis (EPLNM). Before PSM analysis, type of location (P = 0.002), surgical procedure (P = 0.008), number of positive LNs (P = 0.029), number of LNs removed (P = 0.010), lobe of lung cancer (P = 0.031), and vascular invasion (P = 0.049) showed significant differences between the two groups. After PSM analysis, statistically there were differences in type of location (P = 0.034), number of positive LNs (P = 0.008) and vascular invasion (P = 0.049) between them. CONCLUSION: PLN metastasis was a quite common pattern of LN metastasis in N1 station of NSCLC. IPLNM occurred more frequently in central NSCLC and NSCLC with vascular invasion, and thoracotomy was likely to secure more accurate PLN staging. Clinicians should pay great attention to PLN dissection. Follow‐up data will be needed in order to detect the prognosis of IPLNM patients. John Wiley & Sons Australia, Ltd 2019-10-16 2019-12 /pmc/articles/PMC6885437/ /pubmed/31617316 http://dx.doi.org/10.1111/1759-7714.13213 Text en © 2019 The Authors. Thoracic Cancer published by China Lung Oncology Group and John Wiley & Sons Australia, Ltd This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Articles
Zhang, Jiaqi
Liu, Lei
Wang, Guige
Huang, Cheng
Chen, Yeye
Zhang, Ye
Guo, Chao
Li, Shanqing
New perspective to evaluate N1 staging: The peripheral lymph node metastasis status of non‐small cell lung cancer
title New perspective to evaluate N1 staging: The peripheral lymph node metastasis status of non‐small cell lung cancer
title_full New perspective to evaluate N1 staging: The peripheral lymph node metastasis status of non‐small cell lung cancer
title_fullStr New perspective to evaluate N1 staging: The peripheral lymph node metastasis status of non‐small cell lung cancer
title_full_unstemmed New perspective to evaluate N1 staging: The peripheral lymph node metastasis status of non‐small cell lung cancer
title_short New perspective to evaluate N1 staging: The peripheral lymph node metastasis status of non‐small cell lung cancer
title_sort new perspective to evaluate n1 staging: the peripheral lymph node metastasis status of non‐small cell lung cancer
topic Original Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6885437/
https://www.ncbi.nlm.nih.gov/pubmed/31617316
http://dx.doi.org/10.1111/1759-7714.13213
work_keys_str_mv AT zhangjiaqi newperspectivetoevaluaten1stagingtheperipherallymphnodemetastasisstatusofnonsmallcelllungcancer
AT liulei newperspectivetoevaluaten1stagingtheperipherallymphnodemetastasisstatusofnonsmallcelllungcancer
AT wangguige newperspectivetoevaluaten1stagingtheperipherallymphnodemetastasisstatusofnonsmallcelllungcancer
AT huangcheng newperspectivetoevaluaten1stagingtheperipherallymphnodemetastasisstatusofnonsmallcelllungcancer
AT chenyeye newperspectivetoevaluaten1stagingtheperipherallymphnodemetastasisstatusofnonsmallcelllungcancer
AT zhangye newperspectivetoevaluaten1stagingtheperipherallymphnodemetastasisstatusofnonsmallcelllungcancer
AT guochao newperspectivetoevaluaten1stagingtheperipherallymphnodemetastasisstatusofnonsmallcelllungcancer
AT lishanqing newperspectivetoevaluaten1stagingtheperipherallymphnodemetastasisstatusofnonsmallcelllungcancer